The use of a new diagnostic method in patients for the differential diagnosis of Alzheimer's disease (AD)

Abstract

The high diagnostic efficiency of biomarker was asserted, including determination of serum of patients DHEA-s for the early diagnosis and monitoring the effectiveness of therapy and to identify high-risk groups Alzheimer's disease, and chronic brain ischemia